U.S. markets open in 8 hours 6 minutes

Bayer Aktiengesellschaft (BAYRY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
13.65+0.04 (+0.29%)
At close: 03:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close13.61
Bid0.00 x 0
Ask0.00 x 0
Day's Range13.59 - 13.73
52 Week Range12.45 - 18.45
Avg. Volume693,141
Market Cap53.956B
Beta (5Y Monthly)1.15
PE Ratio (TTM)12.41
EPS (TTM)1.10
Earnings DateN/A
Forward Dividend & Yield0.53 (3.86%)
Ex-Dividend DateMay 02, 2022
1y Target Est21.63
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for BAYRY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: Bayer AktiengesellschaftBayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins. The firm has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
    Fair Value
    Economic Moat
    15 days agoMorningstar
View more
  • Benzinga

    Bayer, Exscientia Part Ways On Artificial Intelligence Collaboration

    Exscientia Plc (NASDAQ: EXAI) has ended its collaboration with Bayer AG (OTC: BAYRY) following the achievement of a drug discovery milestone. Exscientia will retain the option to develop one of the two targets being worked on in the collaboration. Bayer and Exscientia signed the deal in January 2020 for €240 million upfront plus undisclosed milestones. At the time, Bayer said the deal would help dramatically accelerate the productivity of drug development. The Exscientia partnership was named in

  • Reuters

    Bayer says it will continue supplying Russia with agricultural inputs

    LONDON (Reuters) -Germany's Bayer said it has decided to continue supplying Russia with essential agricultural inputs, reversing course from comments made in March that supplies for 2023 would be contingent on Russia stopping its attacks on Ukraine. Bayer in March stopped all spending in Russia and Belarus not related to essential products and threatened to withhold essential supplies like seeds and pesticides if Moscow continued its "unprovoked attacks" on Ukraine. Its about-turn on Monday comes in the wake of a deal signed by Russia, Ukraine, the United Nations and Turkey on July 22 to allow grains exports through three Ukrainian Black Sea ports previously blocked by Russia's Black Sea fleet.

  • Reuters

    Bayer launches sustainable agriculture hub to connect U.S. farmers, food and fuel makers

    Agricultural seeds and chemicals maker Bayer AG on Monday launched a digital farming platform that it says will help U.S. growers enact environmentally friendly practices and connect them with companies seeking more sustainable food, feed and biofuel ingredients. The effort will help the seed and chemical giant diversify its revenue stream, capitalizing on a decade-long farm data collection effort. Bayer's ForGround platform will tap weather, soil, seed and farming practice data to make recommendations about how growers can boost soil health, cut emissions and reduce water use and chemical applications.